MedTrace Logo

Feasibility of Holmium-166 Micro Brachytherapy in Head and Neck Tumors

NCT02975739 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2018-09-07

No results posted yet for this study

Summary

The main objective is to establish the feasibility of 166-Holmium microspheres for intratumoral injections in oral squamous cell carcinoma (OSCC) of the tongue.

Participants will receive intratumoral injections with a low radioactive 166-Holmium microspheres followed by surgical resection

Conditions

  • Radioisotopes
  • Head and Neck Neoplasms

Interventions

DEVICE

Holmium-166 (poly L lactic acid) microspheres

Intratumoral injections of Holmium-166 (poly L lactic acid) microspheres

Sponsors & Collaborators

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Marnix G Lam, MD, PhD · UMC Utrecht

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2018-09-05
Completion
2018-09-05

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02975739 on ClinicalTrials.gov